Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease

National Medical Journal of China

Volumn 87, Issue 9, 2007, Pages 614-618

  Wang, Fen ^a   Jia, Jian Ping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; ATP binding cassette transporters; Polymorphism; Single nucleotide; Steroid hydroxylases

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CHOLESTEROL 24 MONOOXYGENASE; CHOLESTEROL OXIDASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NUCLEIC ACID BASE SUBSTITUTION; ONSET AGE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID HYDROXYLASES;

EID: 34249790890     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Simons M, Keller P, Dichgans J, et al. Cholesterol and Alzhermer's disease. Is there a link? Neurology, 2001, 57, 1089-1093.
2. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA, 1999, 96: 7238-7243.
3. Wang N, Tall AR. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler Thromb Vasc Biol, 2003, 23: 1178-1184.
4. Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry, 2002, 7: 899-902.
5. Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol, 2003, 60: 29-35.
6. Sundar PD, Feingold E, Minster RL, et al. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging, 2006 May 22, [Epub ahead of print].
7. Katzov H, Chalmers K, Palmgren J, et al. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β-amyloid metabolism. Hum Mutat, 2004, 23: 358-367.
8. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res, 1990, 31: 545-548.
9. Chinese source.
10. Borroni B, Archetti S, Agosti C, et al. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging, 2004, 25: 747-751.
11. Ingelsson M, Jesneck J, Irizarry MC, et al. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett, 2004, 367: 228-231.
12. Tedde A, Rotondi M, Cellini E, et al. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease. Neurobiol Aging, 2006, 27: 773. e1-773. e3.
13. Myers A, Wavrant De-Vrieze F, Holmans P, et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet, 2002, 114: 235-244.
14. Wahrle SE, Jiang H, Parsadanian M, et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem, 2004, 279: 40987-40993.
15. Koldamova RP, Lefterov IM, Ikonomovic MD, et al. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion. J Biol Chem, 2003, 278: 13244-13256.
16. Shibata N, Kawarai T, Lee JH, et al. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett, 2006, 391: 142-146.
17. Wollmer MA, Streffer JR, Lutjohann D, et al. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging, 2003, 24: 421-426.
18. Chinese source.
19. Srinivasan SR, Li S, Chen W, et al. R219K polymorphism of the ABCA1 gene and its modulation of the variations in serum high-density lipoprotein cholesterol and triglycerides related to age and adiposity in white versus black young adults. The Bogalusa heart study. Metabolism, 2003, 52: 930-934.